Clinical Trial Update: Acetazolamide in Decompensated Heart Failure With Volume OveRload (ADVOR) [Phase 4]

View source ↗

Summary

Phase 4 trial ADVOR evaluating acetazolamide added to diuretic therapy in acute decompensated heart failure with volume overload; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Decompensated Heart Failure

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: Ziekenhuis Oost-Limburg | Conditions: Acute Decompensated Heart Failure, Volume Overload | Phase 4 | Status: COMPLETED | Results posted: 2024-10-28